# Advisor Review - Gemini-3-Flash

**Role:** Academic advisor checking for fatal errors
**Model:** gemini-3-flash-preview (ai_studio)
**Paper:** paper.pdf
**Timestamp:** 2026-03-05T11:58:10.529294
**Route:** Direct Google API + PDF
**Paper Hash:** d37fc45a2f2ba0c8
**Tokens:** 17798 in / 601 out
**Response SHA256:** 4a4b16d2fa6f6859

---

I have reviewed the draft paper "The Price of Pork: France’s Dual-Mandate Ban and the Fiscal Cost of Local–National Connections" for fatal errors. Below are my findings:

### 1. DATA-DESIGN ALIGNMENT
**No fatal errors found.**
- The treatment (cumul ban) became binding at the June 2017 elections. The data covers 2008–2023.
- The paper correctly identifies 2018 as the first post-treatment year ($Post_t$ indicates $t \geq 2018$).
- There are clear post-treatment observations in the main analysis (2020 and 2023).

### 2. REGRESSION SANITY
**No fatal errors found.**
- **Standard Errors:** All standard errors in Table 2 and Table 3 are within plausible ranges for the outcomes (thousands of euros per capita). For example, in Table 2, Col 1, the SE is 0.0110 for a mean of 0.52, which is reasonable.
- **Coefficients:** No coefficients exceed the fatal thresholds. The log outcome in Table 2, Col 7 (-0.0041) is well below the threshold of 10.
- **Impossible Values:** All $R^2$ values are between 0 and 1. Standard errors are positive. No "NA" or "Inf" values appear in the result fields.

### 3. COMPLETENESS
**No fatal errors found.**
- **Placeholders:** I scanned the text and tables for "TBD", "PLACEHOLDER", "XXX", and "NA". None were found in the results. Table 1, 2, and 3 are fully populated.
- **Required Elements:** All regression tables include sample sizes ($N$) and clustered standard errors in parentheses.
- **Consistency:** The Appendix contains the supplementary analyses (Triple-Difference, HonestDiD, Event Studies for secondary outcomes) mentioned in the main text.

### 4. INTERNAL CONSISTENCY
**No fatal errors found.**
- **Numbers match:** The summary statistics in Table 1 (e.g., mean investment of 0.520) match the citations in the text (Section 5.1). The number of constituencies (248 cumulard, 291 non-cumulard) is consistent across the abstract, Section 3.4, Table 1, and the Appendix.
- **Timing:** 2017 is consistently treated as the base year/last pre-treatment year throughout all figures and tables.
- **Specification:** The baseline specification (Constituency + Year FE) is applied consistently across the outcome variables in Table 2.

**ADVISOR VERDICT: PASS**